Skip to main content

Table 1 AD case demographics and neuropathological characteristics for transcriptomics

From: APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain

  APOE Age Sex Braak stage
APOE2 carriers 2/3 93 F 3
2/3 92 F 6
2/3 92 F 3
2/3 90 F 2
2/3 91 F 5
2/3 96 M 5
2/3 67 M 6
2/3 94 M 3
Age ± SD (years)   89.38 ± 9.2   
PMI (range; mean) hours   1.4-3.3; 2.48   
APOE3/3 3/3 80 F 6
3/3 87 F 6
3/3 81 F 6
3/3 91 F 6
3/3 89 F 6
3/3 80 F 6
3/3 80 F 6
3/3 86 M 6
3/3 85 M 6
3/3 83 M 6
3/3 81 M 6
3/3 92 M 6
Age ± SD (years)   84.5 ± 4.4   
PMI (range; mean) hours   2-9; 4.08   
APOE4 carriers 3/4 83 F 6
3/4 80 F 6
3/4 89 F 6
3/4 88 F 6
3/4 84 F 6
3/4 89 F 6
3/4 90 F 6
3/4 87 F 6
3/4 88 M 6
3/4 79 M 6
3/4 76 M 6
3/4 82 M 6
3/4 84 M 6
3/4 91 M 6
3/4 80 M 6
3/4 79 M 6
4/4 79 F 6
4/4 80 F 6
4/4 82 M 6
4/4 82 M 6
4/4 84 M 6
4/4 84 M 6
Age ± SD (years)   83.6 ± 4.2   
PMI (range; mean) hours   1-15; 4035